Healthcare appropriations
NIH gets $14 billion for cancer and flu vaccine work
The House Labor-HHS-Education bill gives NIH $7.46 billion for cancer research and $6.6 billion for allergy and infectious-disease work. It also sets aside at least $270 million for a universal flu vaccine push and allows repairs at the NCI-Frederick site.
The House Labor-HHS-Education bill steers more than $14 billion to two NIH research lines: cancer and allergy and infectious diseases. It also protects money for universal flu vaccine work and covers repairs at the NCI-Frederick research center in Maryland.
- NIH cancer research gets $7.46 billion.
- Up to $30 million could go to repairs at NCI-Frederick.
- Allergy and infectious-disease research gets $6.6 billion.
- At least $270 million is reserved for universal flu vaccine research.
- For patients waiting on a better cancer treatment or a flu shot that covers more strains, the House spending bill is about more than a budget number
For patients waiting on a better cancer treatment or a flu shot that covers more strains, the House spending bill is about more than a budget number. In Washington, Alabama Republican Rep. Robert Aderholt’s Labor-HHS-Education measure for fiscal 2027 sends billions to the National Institutes of Health, or NIH, but it also tells federal researchers where some of that money should go.
That matters because these are not blank dollars. The bill uses caps and set-asides to shape what kind of research gets the strongest federal backing, from lab work to vaccine development.
Cancer research and the Frederick lab
The bill provides $7,462,159,000 for NIH cancer-related work. It also says up to $30,000,000 may be used for facilities repairs and improvements at the National Cancer Institute’s Frederick research center in Maryland.
That repair money is a reminder that research funding is not just about ideas. Buildings, equipment and maintenance can determine how quickly work moves and how much of a lab’s budget is eaten up by keeping the place running.
A flu vaccine target inside the infectious-disease budget
The measure sets aside $6,603,779,000 for NIH allergy and infectious diseases work. It also says not less than $270,000,000 of that total must go to research to develop universal flu vaccines.
That is a specific bet inside a much larger disease portfolio. Instead of leaving the whole account open-ended, the bill names one vaccine goal and protects money for it.
Money with strings attached
The practical effect is simple: the bill would support big federal research programs while steering part of the money toward particular priorities. For scientists, universities and companies that depend on NIH support, those details can shape which projects get traction and which ones stay on the shelf.
The spending bill does not rewrite biomedical research. It does something narrower and, in practice, often more powerful. It decides where the federal government wants the next dollar to land.